According to Fainman, tapping the potential of plasmonics for biomolecule detection systems has been a challenge, because localized optical field scales are usually much larger than the molecules in question. In order to make a useful optical biosensor, he says,"We need to increase the interaction cross-section by finding ways to localize optical interrogation fields ideally to the scales comparable to those of biomolecules."Since that is not currently possible, he and his team used an approach of integrating microfluidics and plasmonics on single chips, allowing fluid to ferry the molecules into the cross-section of the optical field.
Fainman expects the system to be particularly useful in studying large arrays of protein-protein interactions for identifying potential drugs that bind to specific target molecules, which may lead to earlier cancer diagnoses and faster discovery of new drugs. Unlike most current methods,optical detectiondoes not require labeling of molecules with fluorescent or radioactive entities -- labels often hinder interaction by covering up or blocking binding surfaces.
The new platform also carries the advantage of being high throughput and multiplexed, offering researchers an opportunity to examine thousands of arrayed compounds simultaneously, which, he says,"biologists and physicians get very excited about."
Fainman will present these results at Frontiers in Optics (FiO) 2010/Laser Science XXVI -- the 94th annual meeting of the Optical Society (OSA).
No comments:
Post a Comment